Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Undersøges !!

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Balanced translocation in a patient with abortus habitualis and normal karyotype

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The effect of antidepressants on brain volume

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Nyt studie viser, at motion beskytter mod depression

    Research output: Contribution to journalContribution to newspaper - Comment/debateCommunication

  5. Gentagne diploid biparental molae

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Peripheral memory T cells specific for Arginase-1

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Empty peptide-receptive MHC class I molecules for efficient detection of antigen-specific T cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Real-world evidence to guide healthcare policies in oncology

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. undersøges !!

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Cancer immune therapy is now used routinely for the treatment of several solid malignancies, albeit just recently having entered the clinic for treatment of haematological malignancies. Several studies demonstrate that cancer immune therapy is a promising treatment modality for the latter. Especially treatment with chimeric antigen receptor T cells for acute lymphoblastic leukaemia and lymphoma is promising. Other promising treatment modalities are immune check point inhibitors for both lymphoid and myeloid malignancies, as well as therapeutic cancer vaccination targeting tumour antigens.

Translated title of the contributionCancer immune therapy for the treatment of haematological malignancies
Original languageDanish
JournalUgeskrift for Laeger
Volume181
Issue number10
ISSN0041-5782
Publication statusPublished - 4 Mar 2019

ID: 57730184